# FDA Inspection 1177901 - Eyvazzadeh, Aimee, MD, Inc - July 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/eyvazzadeh-aimee-md-inc/12c45e0d-4fbc-40e2-bba2-a94b8b95d477
Source feed: FDA_Inspections

> FDA Inspection 1177901 for Eyvazzadeh, Aimee, MD, Inc on July 14, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1177901
- Company Name: Eyvazzadeh, Aimee, MD, Inc
- Inspection Date: 2022-07-14
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1262937 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/eyvazzadeh-aimee-md-inc/5a89c352-a70a-4f8e-8eac-cd2e565148bf)
- [FDA Inspection 1262937 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/eyvazzadeh-aimee-md-inc/9da8cfb9-e38c-47cc-9a51-e496b9e18701)
- [FDA Inspection 1177901 - 2022-07-14](https://www.keypedia.com/records/fda_inspections/eyvazzadeh-aimee-md-inc/4d5a21fc-cbab-4a14-a2fe-f5bf41555e25)
- [FDA Inspection 1177901 - 2022-07-14](https://www.keypedia.com/records/fda_inspections/eyvazzadeh-aimee-md-inc/1cfa2087-119e-4266-9afb-6658d60df4d8)
- [FDA Inspection 1009661 - 2017-04-13](https://www.keypedia.com/records/fda_inspections/eyvazzadeh-aimee-md-inc/54f7cb6f-0b76-4b37-aeb4-8cce89435994)

Company: https://www.keypedia.com/companies/eyvazzadeh-aimee-md-inc/fdcbdafc-7463-4b5c-a7b5-d812977db6f2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d